Aripiprazole is an atypical antipsychotic medication used primarily in the treatment of schizophrenia and bipolar disorder. It functions as a partial agonist at dopamine d2 receptors, modulating dopamine transmission in the brain. The drug also acts as a partial agonist at serotonin 5-ht1a receptors, contributing to its broad receptor profile. By maintaining dopamine activity within a stable range, it reduces psychotic symptoms such as hallucinations and delusions. It prevents excessive activation of dopamine pathways that can trigger manic episodes in bipolar disorder. Aripiprazole's pharmacological action involves blocking serotonin 5-ht2c receptors, which enhances its antipsychotic efficacy. The combined modulation of these neurotransmitter systems provides symptomatic control without the sedative effect seen with many other antipsychotics.

Aripiprazole is an atypical antipsychotic medication used primarily to treat schizophrenia and bipolar disorder. Pharmacologically it acts as a partial agonist at dopamine d2 receptors and a partial agonist at serotonin 5ht1a receptors. This dual activity helps stabilize dopamine transmission in the brain while reducing overactivity associated with psychosis. Clinically the drug improves symptoms such as hallucinations, delusions, and mood swings, and it is also approved for major depressive disorder as an adjunct. Its mechanism involves binding to receptors in a way that modulates downstream signaling pathways that regulate mood and perception. By fine-tuning neurotransmitter activity Aripiprazole provides therapeutic benefits without fully blocking dopamine, which contributes to its relatively low risk of certain side effects.

Some patients may experience nausea or vomiting as a reaction to Aripiprazole. Weight gain can occur due to changes in appetite and metabolism. Insomnia and restlessness are reported by a minority of users. Headaches and dizziness may appear early in treatment. Less common side effects include tremor and visual disturbances. Long-term use may affect blood sugar levels in susceptible individuals.

Aripiprazole is an atypical antipsychotic used to treat certain mental health conditions. It works by modulating dopamine and serotonin activity in the brain. Some people experience nausea or vomiting when they start the medication. Weight gain can occur as the drug may affect appetite regulation. Restlessness or an inability to sit still is a reported side effect known as akathisia. Changes in heart rhythm have been observed in rare cases. Blood sugar levels may rise slightly and require monitoring. Sleep disturbances such as insomnia or increased drowsiness can also happen.